Home
Fairmount Healthcare Fund II, Director: Apogee Therapeutics APGE Sell · Filed 01/22
Trade details
- Type
- Insider sale
- Amount
- $133,525,000
- Shares · price
- 1,750,000 sh · $76.30 a share
- Held after
- 298,647 sh
- Trade date
- 26/01/22
- Filed
- 26/01/22
- Days to filing
- 0 days
Sold 85.4% of holdings
- Share of holding sold
- 85.4%
Apogee Therapeutics trades, last 26 weeks
What else happened in Apogee Therapeutics around then
Filed or reported within 30 days of the trade day · 25/12/23~02/21Fairmount Healthcare Fund II's recent trades
- Fairmount Healthcare Fund II
SellSpyre Therapeutics
SellSpyre Therapeutics
SYRE
$399.7M
4,684,781 sh
$399.7M
Filed 06/23
Traded 06/23
- Fairmount Healthcare Fund II
BuyViridian Therapeutics, Inc.\DE
BuyViridian Therapeutics, Inc.\DE
VRDN
$20M
1,176,470 sh
$20M
Filed 05/13
Traded 05/11
- Fairmount Healthcare Fund II
BuyZenas BioPharma
BuyZenas BioPharma
ZBIO
$3M
150,000 sh
$3M
Filed 04/01
Traded 03/31
- Fairmount Healthcare Fund II
BuyCrescent Biopharma
BuyCrescent Biopharma
CBIO
$18.2M
1,360,000 sh
$18.2M
Filed 25/12/08
Traded 25/12/04
- Fairmount Healthcare Fund II
BuyViridian Therapeutics, Inc.\DE
BuyViridian Therapeutics, Inc.\DE
VRDN
$10M
454,545 sh
$10M
Filed 25/10/27
Traded 25/10/23
